Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.070
-0.250 (-10.78%)
At close: Nov 4, 2024, 4:00 PM
2.100
+0.030 (1.45%)
After-hours: Nov 4, 2024, 5:11 PM EST

Gain Therapeutics Revenue

In the year 2023, Gain Therapeutics had annual revenue of $55.18K, down -58.40%.

Revenue (ttm)
$55.18K
Revenue Growth
-58.40%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
52.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202355.18K-77.46K-58.40%
Dec 31, 2022132.64K-1.29K-0.96%
Dec 31, 2021133.93K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition